Personalis Inc. (NASDAQ: PSNL) Stock Information | RedChip

Personalis Inc. (NASDAQ: PSNL) Listen to this Section


$5.99
+0.9200 ( +18.15% ) 6.3M

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Market Data


Open


$5.99

Previous close


$5.07

Volume


6.3M

Market cap


$317.92M

Day range


$4.84 - $7.12

52 week range


$0.89 - $7.12

Insider Ownership Transactions

Total Amount Purchased: -38,638.00 | $ -231,441.62

Date Type Amount Purchased Purchaser
2024-01-31 Sale -526.00 Chen Richard
2024-01-31 Sale -716.00 Tachibana Aaron
2023-12-19 Sale -1476.00 Moore Stephen Michael
2023-12-19 Sale -6747.00 Tachibana Aaron
2023-12-19 Sale -4708.00 Chen Richard
2023-11-20 Sale -1344.00 Tachibana Aaron
2023-11-20 Sale -940.00 Chen Richard
2023-11-20 Sale -1722.00 Moore Stephen Michael
2023-11-03 Sale -20459.00 Hall Christopher M

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 May 08, 2024
10-q Quarterly Reports 75 May 08, 2024
4 Insider transactions 1 May 02, 2024
ars Annual reports 1 Apr 02, 2024
def Proxies and info statements 5 Apr 02, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
4 Insider transactions 1 Mar 05, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.